Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach.

[1]  M. Janssen-Heijnen,et al.  Co‐morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer , 2005, The British journal of surgery.

[2]  J. Coebergh,et al.  Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. , 2005, European journal of cancer.

[3]  J. Coebergh,et al.  Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. , 2005, European journal of cancer.

[4]  R. Govindan,et al.  Differential prognostic impact of comorbidity. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Coebergh,et al.  Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study , 2004, European journal of gastroenterology & hepatology.

[6]  J. Coebergh,et al.  Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer , 2004, Thorax.

[7]  Edward L Spitznagel,et al.  Prognostic importance of comorbidity in a hospital-based cancer registry. , 2004, JAMA.

[8]  J. Coebergh,et al.  Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients , 2004, British Journal of Cancer.

[9]  A. Zaslavsky,et al.  Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Michael Simoff,et al.  Impact of comorbidity on lung cancer survival , 2003, International journal of cancer.

[11]  E. Gore,et al.  Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. , 2002, International journal of radiation oncology, biology, physics.

[12]  M. Bousamra,et al.  Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.

[13]  J. Piccirillo,et al.  Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. , 2002, The Journal of thoracic and cardiovascular surgery.

[14]  W. Gianni,et al.  Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[16]  P. Alken,et al.  The Difficult Stone Case: Definition and Management , 2001, European Urology.

[17]  J. Birkmeyer,et al.  Operative mortality with elective surgery in older adults. , 2001, Effective clinical practice : ECP.

[18]  M. Janssen-Heijnen,et al.  The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population‐based study , 2001, BJU international.

[19]  R. Yancik,et al.  Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Piccirillo,et al.  Importance of Comorbidity in Head and Neck Cancer , 2000, The Laryngoscope.

[21]  Kil,et al.  Comorbidity in patients with prostate cancer and its relevance to treatment choice , 1999, BJU international.

[22]  A S Kosinski,et al.  A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. , 1999, Journal of clinical epidemiology.

[23]  D. Kerr,et al.  Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group. , 1998, European journal of cancer.

[24]  J. Coebergh,et al.  Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. , 1998, Lung cancer.

[25]  G. Lyman,et al.  Comorbidity and functional status are independent in older cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Jager,et al.  Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  H. Adami,et al.  International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension , 1995, International journal of cancer.

[28]  C. Bolliger,et al.  Exercise capacity as a predictor of postoperative complications in lung resection candidates. , 1995, American journal of respiratory and critical care medicine.

[29]  W. Forman.  The role of chemotherapy and adjuvant therapy in the management of colorectal cancer , 1994, Cancer.

[30]  D. Trichopoulos,et al.  Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma , 1993, Cancer Causes & Control.

[31]  Sati Mazumdar,et al.  Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.

[32]  F Parazzini,et al.  The epidemiology of endometrial cancer. , 1991, Gynecologic oncology.

[33]  A. Miller,et al.  Coffee and alcohol as determinants of risk of pancreas cancer: A case‐control study from toronto , 1991, International journal of cancer.

[34]  A. Feinstein,et al.  The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. , 1974, Journal of chronic diseases.

[35]  A. Wolk,et al.  The role of diabetes mellitus in the aetiology of renal cell cancer , 1999, Diabetologia.

[36]  R. Damhuis,et al.  Resection rates and postoperative mortality in 7,899 patients with lung cancer. , 1996, The European respiratory journal.

[37]  N. Petrelli,et al.  Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial , 1995, Cancer.

[38]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[39]  T. Hakulinen,et al.  A computer program package for relative survival analysis. , 1985, Computer programs in biomedicine.